Page 2 - Jeffreym Jonas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeffreym jonas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeffreym Jonas Today - Breaking & Trending Today

Karuna Therapeutics, Inc. (NASDAQ:KRTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price objective […] ....

Sakhalinskaya Oblast , Jeffreym Jonas , Stephenk Brannan , Securities Exchange Commission , Ameriprise Financial Inc , First Horizon Advisors Inc , Karuna Therapeutics Inc , Royal Bank , Sei Investments Co , Karuna Therapeutics Company Profile , Morgan Stanley , Life Insurance Co , Wells Fargo Company , Financial Services Group Inc , Karuna Therapeutics , Get Free Report , Marketbeat Ratings , Exchange Commission , Director Jeffrey , Horizon Advisors , Services Group , Metropolitan Life Insurance , Life Insurance , Get Free , Karuna Therapeutics Daily , Nasdaq Krtx ,

Karuna Therapeutics (NASDAQ:KRTX) Receives Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a $300.00 target price on the stock. Several other research firms also recently weighed in on KRTX. Cantor Fitzgerald reiterated a neutral rating and […] ....

United States , Jeffreym Jonas , Troya Ignelzi , Financial Services Group Inc , Karuna Therapeutics Company Profile , Lazard Asset Management , Morgan Stanley , Exchange Traded Concepts , Almanack Investment Partners , Cantor Fitzgerald , First Horizon Advisors Inc , Karuna Therapeutics Inc , Securities Exchange Commission , Wells Fargo Company , Karuna Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Get Free Report , Director Jeffrey , Exchange Commission , Horizon Advisors , Services Group , Asset Management , Investment Partners , Karuna Therapeutics Daily ,

MYDA Advisors LLC Makes New $1.45 Million Investment in Karuna Therapeutics, Inc. (NASDAQ:KRTX)

MYDA Advisors LLC purchased a new stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 8,000 shares of the company’s stock, valued at approximately $1,453,000. Several other hedge funds have also recently made changes […] ....

United States , Lauriej Olson , Jeffreym Jonas , Sectoral Asset Management Inc , Securities Exchange Commission , Myda Advisors , Blackrock Inc , Karuna Therapeutics Inc , Stifel Financial Corp , Morgan Stanley , Clearbridge Investments , Prudential Financial Inc , Karuna Therapeutics , Free Report , Financial Corp , Asset Management , Director Jeffrey , Exchange Commission , Director Laurie , Get Free Report , Karuna Therapeutics Daily , Nasdaq Krtx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Karuna Therapeutics (NASDAQ:KRTX) Now Covered by Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a research report sent to investors on Tuesday, Marketbeat reports. The brokerage issued an overweight rating and a $225.00 price target on the stock. A number of other research analysts have also recently commented on the stock. JPMorgan Chase […] ....

United States , Jeffreym Jonas , Andrew Miller , Peter Jeffrey Conn , Eric Elenko , Troya Ignelzi , Karuna Therapeutics Inc , Royal Bank , Advisors Inc , Financial Services Group Inc , Jpmorgan Chase Co , Morgan Stanley , Wells Fargo Company , First Horizon Advisors Inc , Wells Fargo , Karuna Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Jeffrey , Horizon Advisors , Services Group , Parallel Advisors , Karuna Therapeutics Daily , Nasdaq Krtx , Initiated Coverage ,